Drug: LAMIVUDINE. Injury: Maternal exposure during pregnancy Quarter: 2016Q3
Total Records: 12 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
94625723 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 26.00 YR | F | 0 | 20160713 | ZA |
94625933 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 34.00 YR | F | 0 | 20160713 | ZA |
94991253 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160720 | ZA |
94991273 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160720 | US |
94991283 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160720 | ZA |
94991293 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160720 | US |
96072753 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 24.00 YR | F | 1 KG | 20160725 | ZA |
97054463 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160720 | IT |
114609393 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 30.00 YR | F | 0 | 20160704 | TH |
118830632 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 27.00 YR | F | 0 | 20160721 | PT |
127359921 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 29.00 YR | F | 0 | 20160913 | FR |
127892571 | LAMIVUDINE. | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160928 | CA |
Total Records: 12 Number of Pages: 1